These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 2886324)

  • 21. Cimetidine impairs the elimination of theophylline and antipyrine.
    Roberts RK; Grice J; Wood L; Petroff V; McGuffie C
    Gastroenterology; 1981 Jul; 81(1):19-21. PubMed ID: 7239117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between antipyrine clearance and cytochrome P-450 level after phenobarbital induction in rat.
    Chang SL; Nelson SD; Levy RH
    Drug Metab Dispos; 1984; 12(1):139-41. PubMed ID: 6141905
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of levamisole on cell sensitivity in rats with experimental Heymann's nephritis.
    Tareyeva IE; Savitsky SN; Gordovskaya NB; Varshavsky VA
    Acta Med Hung; 1984; 41(2-3):137-41. PubMed ID: 6379593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antipyrine pharmacokinetics in the pregnant rat.
    Dean M; O'Donnell L; Penglis S; Stock B
    Drug Metab Dispos; 1980; 8(4):265-7. PubMed ID: 6105062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration of the pharmacokinetics and metabolism of propranolol and antipyrine elicited by indwelling catheters in the rat.
    Chindavijak B; Belpaire FM; De Smet F; Bogaert MG
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1075-9. PubMed ID: 3418510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The immunobiological properties of trimezon and levamisole on models of humoral and cell-mediated immunogenesis].
    Liubin GS; Kuz'mitskiĭ BB
    Eksp Klin Farmakol; 1997; 60(1):50-2. PubMed ID: 9162286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipyrine and acetaminophen kinetics in the rat: comparison of data based on blood samples from the cut tail and a cannulated femoral artery.
    Johannessen WM; Tyssebotn IM; Aarbakke J
    J Pharm Sci; 1982 Dec; 71(12):1352-6. PubMed ID: 7153883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interindividual variation in apparent volumes of distribution of antipyrine in the rat.
    Johannessen W; Aarbakke J
    J Pharm Pharmacol; 1982 May; 34(5):327-8. PubMed ID: 6123573
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of levamisole on hemolysin production in the spleen of rats after chronic administration of thyrotropin].
    Samuleva SV; Degtiar' DA
    Probl Endokrinol (Mosk); 1983; 29(5):86-8. PubMed ID: 6647436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of water deprivation on antipyrine disposition kinetics in rats.
    Prasad PP; Niazi S
    Biopharm Drug Dispos; 1984; 5(2):195-8. PubMed ID: 6743786
    [No Abstract]   [Full Text] [Related]  

  • 31. Suppressive effects of two bioresponse modifiers, krestin and levamisole, on 5-azacytidine-induced digital defects in rats.
    Kurishita A
    Teratog Carcinog Mutagen; 1990; 10(5):409-15. PubMed ID: 1706894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effects of immunosuppressive and immunoenhancing agents on rat experimental periodontitis].
    Horino K; Misaki H; Ohfuji Y; Yamashita K; Yoshie H; Hara K
    Nihon Shishubyo Gakkai Kaishi; 1988 Sep; 30(3):827-35. PubMed ID: 3253352
    [No Abstract]   [Full Text] [Related]  

  • 33. [The dose effect of sulpyrin on the metabolism and excretion rates in rats (author's transl)].
    Nogami H; Hanano M; Awazu S; Imaoka K
    Yakugaku Zasshi; 1973 Dec; 93(12):1593-602. PubMed ID: 4361310
    [No Abstract]   [Full Text] [Related]  

  • 34. [A pharmacokinetic study on the metabolism and excretion of sulpyrin in the rats (author's transl)].
    Nogami H; Hanano M; Awazu S; Imaoka K
    Yakugaku Zasshi; 1973 Dec; 93(12):1585-92. PubMed ID: 4361309
    [No Abstract]   [Full Text] [Related]  

  • 35. Letter: Immunopotentiation by levamisol.
    Fischer GW; Podgore JK; Bass JW
    Lancet; 1975 May; 1(7916):1137. PubMed ID: 49491
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of microdialysis for the study of drug kinetics: some methodological considerations illustrated with antipyrine in rat frontal cortex.
    Patsalos PN; Abed WT; Alavijeh MS; O'Connell MT
    Br J Pharmacol; 1995 Jun; 115(3):503-9. PubMed ID: 7582464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose- and time-dependent effect of levamisole on the elimination of antipyrine in the rat.
    Svensson CK; Liu LL
    Drug Metab Dispos; 1987; 15(3):432-4. PubMed ID: 2886324
    [No Abstract]   [Full Text] [Related]  

  • 38. [The relationship between antipyrine kinetics and the change in the seromucoid content of rat plasma under the influence of the immunomodulator levamisole].
    Kupchikov VV; Bender KI; Lutsevich AN; Gangnus VS
    Farmakol Toksikol; 1990; 53(5):55-8. PubMed ID: 2253753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-dependent pharmacokinetics of antipyrine in the rat.
    Pollack GM; Li RC; Shen DD
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):69-81. PubMed ID: 6729251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-dependent effect of propafenone on in vivo drug metabolism in the rat.
    Chong MT; Svensson CK
    Res Commun Chem Pathol Pharmacol; 1987 Nov; 58(2):147-56. PubMed ID: 3423421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.